āagman

Not investment advice. Data and computed figures, for information only.

Glenmark Pharmaceuticals Ltd

NSE: GLENMARKF&O
₹2,226.70
−₹23.80 (−1.06%)
NSE · 16 Oct 2026, close
NSE
As of 31 Mar 2026
Market Cap
₹64,714 Cr
CMP
₹2,226.70
52-wk High / Low
₹2,538 / 1,793
P/E
20.7
P/B
6.2
Book Value
₹372.0
Div Yield
0.22%
ROCE
40.0%
ROE
23.6%
Face Value
₹1
D/E
0.06

Price+16.6% over 1Y

āagman read

Computed by āagman
Derived from 12 years and 15 quarters of filings. Not reported by the company.
As of 16 Oct 2026
How we compute these
Piotroski F-Score
8
/ 9
8 of 9 F-score tests passed
Graham Number
₹636
√(22.5 × EPS × book value per share)
ROIC
24.7%
vs 11.2% sector median
Cash flow to profit
2.53
CFO / PAT
Above 1.0 = operating cash flow exceeded reported profit
Margin change
+223
bps OPM YoY
Operating margin vs the same quarter last year
Sustainable growth
22.5%
ROE × earnings retention ratio
ROE stability
11.7
pp σ
Standard deviation of ROE across periods. Lower = more stable
Holder deltas
QoQ
pp
Prom +0.00FII +0.54DII −0.68
Latest quarter vs the previous one
Cash-accrual divergence
−11.6%
of assets
Low = accruals track cash flow
Strengths
+Borrowings are down 85.1% since FY2016 (3988 to 594)
+Price trades above its 200-day moving average (1.0x)
+Piotroski F-Score of 8/9 is in the strong band (≥7)
+PE of 20.7x is below the sector median of 45.9x
Watch-outs

Peer comparison

Peers
NameP/EMar Cap ₹ CrROCE %ROE %

Quarterly results

Consolidated basis (as filed) · ₹ Cr · 13 quarters
As of 30 Jun 2026
Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales3,0363,2072,5073,0633,2443,4343,3883,2563,2646,0473,9013,7714,018
Expenses2,5992,7452,7152,5592,6562,8322,7872,6952,6843,6873,0313,0083,214
Operating Profit437462−2095045886026005615812,360870763805
OPM %14.4%14.4%−8.3%16.5%18.1%17.5%17.7%17.2%17.8%39.0%22.3%20.2%20.0%
Other Income−32−20587351313931−361−297−1,184−140−18466
Interest112121134149404852675866414354
Depreciation142141147151118120123125130141154148173
Profit before tax151−6−403555462473456896967534388643
Net Profit173−62−331−1,214340354348447610403301483
EPS (₹)5.31−2.90−12.45−43.1712.0612.5512.330.161.6621.6314.2910.6817.11

Profit & Loss

As of 30 Jun 2026
Consolidated · ₹ Cr · 12 years + TTM
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales6,5637,5629,0799,0749,86510,64110,94412,30511,58311,81313,32216,98317,737
Expenses5,3486,1257,0437,4578,2808,9428,8609,9789,94810,61810,97012,41012,940
Operating Profit1,2141,4372,0371,6171,5861,6992,0842,3271,6351,1952,3514,5724,797
OPM %18.5%19.0%22.4%17.8%16.1%16.0%19.0%18.9%14.1%10.1%17.6%26.9%27.0%
Other Income−18020−448937519195−101−10336−259−1,805−1,443
Interest190179237286335377353298349516207209204
Depreciation300234264302326417444487569582486573617
Profit before tax5441,0441,4911,1191,3011,0961,3821,4417074341,3991,9852,533
Net Profit2097431,109804925776970994377−1,4341,0471,3621,798
EPS (₹)7.7226.3339.2928.4932.7827.5034.3833.3710.53−53.2237.1148.2663.71

Balance Sheet

As of 30 Jun 2026
Consolidated · ₹ Cr
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Jun 2026
Equity Capital272828282828282828282828—
Reserves1,7563,6014,4645,1355,5776,0427,0369,0589,4467,8208,82110,484—
Borrowings3,8003,9884,7244,6394,4494,8694,9863,9624,6081,2312,473594—
Other Liabilities2,7262,5752,5482,7933,2353,7293,5244,0035,2895,2794,6698,801—
Total Liabilities8,30910,19311,76412,59513,28914,66815,57517,05219,37114,35815,99119,907—
Fixed Assets2,0152,5942,7553,0303,6705,0295,1295,8875,4224,2104,4875,915—
CWIP4775437081,1221,3991,2221,3821,0101,190662835909—
Investments1717161530252550457905642—
Other Assets5,7997,0398,2858,4298,1908,3939,04010,10512,7158,69710,61313,041—
Total Assets8,30910,19311,76412,59513,28914,66815,57517,05219,37114,35815,99119,907—

Cash Flows

As of 31 Mar 2026
Consolidated · ₹ Cr
Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity8544823456571,6481,3241,3921,1311,109625−265−8283,445
Cash from Investing Activity−566−712−950−1,001−1,003−883−774−662−316−5154,38758−1,237
Cash from Financing Activity−98199699543−468−739−445−442−520−77−3,906787−2,709
Net Cash Flow190−3193199177−297174282723221517−501

Ratios

As of 31 Mar 2026
13 periods
Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %15.016.019.021.015.015.014.015.016.010.012.019.040.0
ROE %————————————23.6
EPS (₹)19.997.7226.3339.2928.4932.7827.5034.3833.3710.53−53.2237.1148.26
Book Value (₹)————————————372.0
Face Value (₹)————————————1
P/E————————————20.7
Div Yield %————————————0.22
NPM %9.13.39.812.38.89.07.28.88.13.3−11.88.09.0
OPM %18.018.019.022.018.016.016.019.019.014.010.018.027.0
D/E1.102.131.101.050.900.790.800.710.440.490.160.280.06
P/B————————————6.2

Growth

As of 11 Oct 2026
Compounded sales growth
10 years+8.0%
5 years+9.0%
3 years+14.0%
TTM+33.0%
Compounded profit growth
10 years+12.0%
5 years+19.0%
3 years+61.0%
TTM+134.0%
Stock price CAGR
10 years+10.0%
5 years+34.0%
3 years+43.0%
Last year+18.0%
Return on equity
10 years7.0%
5 years2.0%
3 years−3.0%
Last year24.0%

Shareholding pattern

As of 31 Mar 2026
Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters46.50%46.50%46.54%46.54%46.62%46.63%46.65%46.65%46.65%46.65%46.65%46.65%
FIIs34.78%34.78%30.75%32.62%28.51%25.84%24.12%22.47%21.38%23.15%20.35%20.89%
DIIs6.02%6.02%6.62%6.93%6.75%9.16%10.96%10.40%13.36%14.60%19.28%18.60%
Government0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.04%0.04%0.04%0.04%0.04%
Public12.69%12.69%16.10%13.90%18.12%18.38%18.27%20.46%18.58%15.56%13.70%13.81%
No. of shareholders88,10388,1031,53,5071,20,4301,54,6252,50,8513,10,5162,85,4611,99,4511,92,7241,96,1052,11,418
Change since Jun 2023 (pp)
Promoters +0.15FIIs −13.89DIIs +12.58Public +1.12

Documents

As of 11 Oct 2026
Announcements
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseClosure of Trading WindowAnnouncement under Regulation 30 (LODR)-Press Release / Media ReleaseAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationShareholder Meeting / Postal Ballot-Scrutinizer''s Report
Annual reports
Annual Report 2026Annual Report 2025Annual Report 2024Annual Report 2023Annual Report 2022
Credit ratings
Rating updateRating updateRating updateRating updateRating update
Concalls
Aug 2026TranscriptAug 2026PPTAug 2026RecordingJun 2026TranscriptJun 2026PPTJun 2026RecordingMay 2026PPTFeb 2026TranscriptFeb 2026PPTFeb 2026RecordingNov 2025TranscriptNov 2025PPTNov 2025Recording

Corporate actions

As of 31 Aug 2026
31 Aug 2026DIVIDENDDividend - Rs 2.50 Per Share—
3 Oct 2025DIVIDENDInterim Dividend - Rs 2.50 Per Share—
15 Sep 2025DIVIDENDDividend - Rs 2.50 Per Share—
13 Sep 2024DIVIDENDDividend - Rs 2.50 Per Share—
18 Sep 2023DIVIDENDDividend - Rs 2.50 Per Share—
12 Sep 2022DIVIDENDAnnual General Meeting/Dividend - Rs 2.50 Per Share—
8 Sep 2021DIVIDEND Annual General Meeting/Dividend - Rs 2.50 Per Share—
17 Sep 2020DIVIDEND Annual General Meeting/Dividend - Rs 2.50 Per Share—
19 Sep 2019DIVIDEND Annual General Meeting/Dividend - Rs 2 Per Share—
19 Sep 2018DIVIDEND Annual General Meeting/Dividend Rs 2 Per Share—
20 Sep 2017DIVIDEND Annual General Meeting/Dividend - Rs 2/- Per Share—
3 Aug 2016DIVIDEND Annual General Meeting/ Dividend - Rs 2/- Per Share—
10 Sep 2015DIVIDEND Annual General Meeting/ Dividend - Rs 2/- Per Share—
10 Jul 2014DIVIDENDAnnual General Meeting / Dividend - Rs 2/- Per Share—
18 Jul 2013DIVIDENDAnnual General Meeting / Dividend - Rs 2/- Per Share—
19 Jul 2012DIVIDENDAnnual General Meeting / Dividend Rs 2 Per Share—
28 Jul 2011DIVIDENDAnnual General Meeting And Dividend Re.0.40 Per Share—
16 Sep 2010DIVIDENDAnnual General Meeting And Dividend Re.0.40 Per Share—
Fundamentals from a third-party compiler of exchange filings; prices from the exchanges. Not investment advice.© 2026 āagman